ArticleActa pharmaceutica Sinica. B2019

SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade.

Mingxia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.